Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development
The Pharma Data
DECEMBER 2, 2020
Lisa is a senior pharmaceutical executive with more than 20 years of experience in research and drug discovery. Kazumi Shioshaki, newly appointed Board member of Enthera, stated: “Enthera Pharmaceuticals is an exciting young biotech, with an innovative and unique approach to treating underserved autoimmune disorders. 3, 2020 08:00 UTC.
Let's personalize your content